Martin Javier San, Chief Medical Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 12,706 shares at $35.64 ($450K) on 2024-01-05, disclosed to the SEC on 2024-01-08.
Scheduled sale ($450k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.11 | 800 | $27K | 6.1% |
| 2 | $35.03 | 3,100 | $109K | 24.1% |
| 3 | $35.64 | 4,403 | $157K | 34.9% |
| 4 | $35.64 | 4,403 | $157K | 34.9% |
| Total | $35.39 avg | 12,706 | $450K | 100% |
| Filing → |
| ATHA | SELL | 2025-07-02 | $3K | — | Filing → |
| ATHA | SELL | 2025-01-03 | $6K | — | Filing → |
| ARWR | SELL | 2023-11-22 | $991K | — | Filing → |